Analysis of circulating metabolites to differentiate Parkinson’s disease and essential tremor

[Display omitted] •Levels of α-synuclein in plasma and cerebral CSF distinguish PD from ET.•Metabolic pathway profiles in plasma and CSF distinguish PD from ET.•Increase in plasma NADH/NAMPT support pentose phosphate pathway dysregulation in PD. Parkinson’s disease (PD) and essential tremor (ET) are...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience letters 2022-01, Vol.769, p.136428-136428, Article 136428
Hauptverfasser: Ostrakhovitch, Elena A., Song, Eun-Suk, Macedo, Jessica K.A., Gentry, Matthew S., Quintero, Jorge E., van Horne, Craig, Yamasaki, Tritia R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •Levels of α-synuclein in plasma and cerebral CSF distinguish PD from ET.•Metabolic pathway profiles in plasma and CSF distinguish PD from ET.•Increase in plasma NADH/NAMPT support pentose phosphate pathway dysregulation in PD. Parkinson’s disease (PD) and essential tremor (ET) are two common adult-onset tremor disorders in which prevalence increases with age. PD is a neurodegenerative condition with progressive disability. In ET, neurodegeneration is not an established etiology. We sought to determine whether an underlying metabolic pattern may differentiate ET from PD. Circulating metabolites in plasma and cerebrospinal fluid (CSF) were analyzed using gas chromatography-mass spectroscopy. There were several disrupted pathways in PD compared to ET plasma including glycolysis, tyrosine, phenylalanine, tyrosine biosynthesis, purine and glutathione metabolism. Elevated α-synuclein levels in plasma and CSF distinguished PD from ET. The perturbed metabolic state in PD was associated with imbalance in the pentose phosphate pathway, deficits in energy production, and change in NADPH, NADH and nicotinamide phosphoribosyltransferase levels. This work demonstrates significant metabolic differences in plasma and CSF of PD and ET patients.
ISSN:0304-3940
1872-7972
DOI:10.1016/j.neulet.2021.136428